• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-PD-1 associated retroperitoneal fibrosis.

作者信息

Daoussis Dimitrios, Kraniotis Pantelis, Kalofonou Foteini, Kalofonos Haralabos

机构信息

Department of Rheumatology, Patras University Hospital, University of Patras Medical School.

Department of Radiology, Patras University Hospital, Patras, Greece.

出版信息

Rheumatology (Oxford). 2021 Sep 1;60(9):e329-e330. doi: 10.1093/rheumatology/keab264.

DOI:10.1093/rheumatology/keab264
PMID:33729466
Abstract
摘要

相似文献

1
Anti-PD-1 associated retroperitoneal fibrosis.抗程序性死亡蛋白1相关的腹膜后纤维化
Rheumatology (Oxford). 2021 Sep 1;60(9):e329-e330. doi: 10.1093/rheumatology/keab264.
2
Severe polyradiculoneuritis associated with the combination of ipilimumab and pembrolizumab in a lung cancer patient.一名肺癌患者中与伊匹木单抗和帕博利珠单抗联合使用相关的严重多神经根神经炎。
Neurol India. 2018 Mar-Apr;66(2):509-511. doi: 10.4103/0028-3886.227311.
3
Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial.雷莫芦单抗联合帕博利珠单抗治疗既往治疗的晚期非小细胞肺癌、胃食管交界处癌或尿路上皮癌患者（JVDF）：一项多队列、非随机、开放标签、1a/1b 期临床试验。
Lancet Oncol. 2019 Aug;20(8):1109-1123. doi: 10.1016/S1470-2045(19)30458-9. Epub 2019 Jul 10.
4
Real-World Experience With Pembrolizumab in Patients With Advanced Lung Cancer.帕博利珠单抗治疗晚期肺癌患者的真实世界经验
Am J Ther. 2019 Jul/Aug;26(4):e537-e538. doi: 10.1097/MJT.0000000000000762.
5
PD-1 Blockade-Induced Pruritus Treated with a Mu-Opioid Receptor Antagonist.用μ-阿片受体拮抗剂治疗程序性死亡蛋白1阻断诱导的瘙痒症。
N Engl J Med. 2018 Oct 18;379(16):1578-1579. doi: 10.1056/NEJMc1805637.
6
Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer.癌症免疫检查点抑制剂治疗开始后出现亚急性皮肤型红斑狼疮。
Lupus. 2021 Mar;30(3):531-533. doi: 10.1177/0961203320983448. Epub 2021 Jan 6.
7
Pembrolizumab as first-line therapy in programmed death ligand 1-positive advanced lung cancer: Is it as effective as we think it is?帕博利珠单抗作为程序性死亡配体1阳性晚期肺癌的一线治疗：它是否如我们所想的那样有效？
Cancer. 2017 Oct 15;123(20):3872-3874. doi: 10.1002/cncr.30868. Epub 2017 Jun 29.
8
Rapid Disease Progression of Advanced Non-small Cell Lung Cancer Five Months after Cessation of Pembrolizumab.帕博利珠单抗停药五个月后晚期非小细胞肺癌快速进展
Acta Med Okayama. 2020 Oct;74(5):423-425. doi: 10.18926/AMO/60802.
9
Protocol for Desensitization to Atezolizumab and Bevacizumab After Severe Anaphylaxis in the Treatment of Lung Adenocarcinoma.肺腺癌治疗中严重过敏反应后阿替利珠单抗和贝伐单抗脱敏方案
J Investig Allergol Clin Immunol. 2021 Jun 22;31(3):265-267. doi: 10.18176/jiaci.0637. Epub 2020 Aug 26.
10
Early fatal hemoptysis after first-dose, first-line pembrolizumab in a central lung cancer: did tumor shrinkage matter?一线帕博利珠单抗治疗首剂后早期致命性咯血：肿瘤退缩是否重要？
Immunotherapy. 2019 Feb;11(3):161-166. doi: 10.2217/imt-2018-0136.

引用本文的文献

1
Fibroblast-directed PET imaging reveals a case of retroperitoneal fibrosis after immunotherapy for metastatic urothelial cancer of the upper tract.成纤维细胞导向的PET成像揭示了一例上尿路转移性尿路上皮癌免疫治疗后发生腹膜后纤维化的病例。
Urol Case Rep. 2025 Jun 16;61:103105. doi: 10.1016/j.eucr.2025.103105. eCollection 2025 Jul.
2
Overview of F18-FDG uptake patterns in retroperitoneal pathologies: imaging findings, pitfalls, and artifacts.腹膜后病变 F18-FDG 摄取模式概述：影像学表现、陷阱和伪影。
Abdom Radiol (NY). 2024 May;49(5):1677-1698. doi: 10.1007/s00261-023-04139-x. Epub 2024 Apr 23.
3
A First Suspected Case of Fibrosing Mediastinitis After Anti-PD-1 Therapy.
首例抗PD-1治疗后疑似纵隔纤维化病例
JACC Case Rep. 2022 Oct 19;4(20):1363-1365. doi: 10.1016/j.jaccas.2022.09.002.
4
Case Report: A Programmed Cell Death-1 Inhibitor-Related Abdominal Fibroinflammatory Reaction Affecting Multiple Organs in A Non-Small-Cell Lung Cancer Patient.病例报告：程序性细胞死亡受体 1 抑制剂相关的腹部纤维炎性反应影响非小细胞肺癌患者的多个器官。
Front Immunol. 2022 Jul 1;13:874932. doi: 10.3389/fimmu.2022.874932. eCollection 2022.